We are excited to participate at the Onco Cell Therapy Summit, Jun 29-30, 2022!
Visit our booth# 6 to interact with our experts and learn how to manage regulatory and drug safety commitments for your advanced medicinal products and complex therapies.
Speaker Presentation: Designing a Safety and Risk Management System for Cellular Therapies
The need for a risk evaluation and mitigation strategy (REMS) or a risk management plan (RMP) is essential to ensure risk–benefit balance for complex cellular therapies. Hear from our expert Dr. Vineet Kacker (Co-founder, Global Technical Head and Managing Director) where he will be presenting his insights on designing a safety plan for cellular therapies.
Round Table: “Role of Well-planned Safety and Risk Management Strategies in Addressing Regulatory Challenges”
Join us for the roundtable session at the conference led by Dr. Vineet where he discusses the importance of early planning to ensure product safety and well-planned risk mitigation strategies along with active engagement with regulatory authorities.
About Onco Cell Therapy Summit
The Onco Cell Therapy Summit (OCTS) is the industry-led meeting covering the full range of autologous and allogeneic cell product advancements. The Summit, features pioneering biopharma, academia, and solution-providers, which will address all innovative companies in research, manufacturing challenges, and clinical progress of CAR T, TCR T, TILs, Macrophages, and NK cells in treating haematological and solid tumors. The conference aims at discussing the opportunities generated from recent clinical and technological data, and how they are tackling the most pressing industry challenges to get effective treatments to patients.